CoreWeave (CRWV) vs Nebius (NBIS): Which AI Cloud Stock Offers Better Returns in 2025?

Key Takeaways

Table of Contents

CoreWeave delivered $4.92B in 2025 revenues alongside a massive $66.8B backlog, though it shoulders approximately $14B in debt with planned 2026 capex of $30–35B
Nebius achieved $227.7M in 2025 revenues while maintaining $3.7B cash reserves, aiming for $7–9B ARR by late 2026
A significant $3B five-year partnership with Meta was secured by Nebius in late 2025, adding to its existing Microsoft collaboration
Wall Street assigns Moderate Buy ratings to both companies — CoreWeave targets $121.06 average, while Nebius sits at $157.09
CoreWeave represents established infrastructure scale; Nebius presents higher-risk, higher-reward opportunity with superior financial positioning

Both CoreWeave and Nebius operate within the emerging “neocloud” sector. These platforms specialize in delivering GPU-intensive cloud infrastructure tailored for artificial intelligence applications, distinguishing them from conventional cloud service providers.

Each company has captured significant market interest. However, their investment narratives diverge considerably.

CoreWeave’s recent public debut positioned it as a prominent player in AI infrastructure. The firm generated $4.92 billion in revenue throughout 2025. Additionally, it concluded the fiscal year with an impressive $66.8 billion revenue backlog.

CoreWeave, Inc. Class A Common Stock, CRWV

This substantial backlog provides CoreWeave with exceptional revenue predictability. It demonstrates sustained market appetite for specialized AI cloud infrastructure from independent providers.

However, maintaining operations demands substantial financial resources. CoreWeave deployed $14.9 billion in capital investments during 2025 and projects spending between $30 and $35 billion throughout 2026. The organization also maintains approximately $14 billion in outstanding debt, accompanied by significant lease obligations.

While CoreWeave’s expansion is impressive, it necessitates considerable capital infusion. This transforms the investment thesis into both an operational delivery challenge and a capital management proposition.

Nebius: Earlier Stage, Stronger Balance Sheet

Nebius operates at an earlier development phase. The company generated $227.7 million in 2025 revenues and closed the period with $1.25 billion in annual recurring revenue.

Nebius Group N.V., NBIS

Additionally, Nebius maintains approximately $3.7 billion in liquid cash. This financial cushion enables growth investments without immediately requiring significant leverage.

Leadership has established ambitious targets of $7 to $9 billion in ARR by year-end 2026. This represents exceptional growth from current revenue levels.

The firm has also locked in partnerships with industry giants. Nebius finalized a $3 billion, five-year arrangement with Meta during late 2025. This followed an earlier substantial agreement with Microsoft.

These partnerships validate that leading AI corporations are increasingly comfortable leveraging specialized, independent cloud infrastructure providers for their computational needs.

Analyst Perspectives

Investment analysts maintain positive outlooks on both stocks. CoreWeave receives a Moderate Buy consensus across 32 analysts, comprising 19 buy recommendations, 11 hold ratings, and 2 sell opinions. The consensus price target stands at $121.06.

Nebius similarly earns a Moderate Buy rating, with 2 Strong Buy calls, 9 Buy ratings, 1 Hold, and 1 Sell recommendation. Its consensus target reaches $157.09.

Both price objectives indicate analysts anticipate appreciation potential, albeit for distinct reasons.

CoreWeave presents clearer financial modeling opportunities. Its revenue streams and contract backlog are substantial and thoroughly documented.

Nebius relies more heavily on successfully achieving ambitious growth milestones. This creates valuation complexity but potentially greater returns if execution meets expectations.

Investment Considerations

CoreWeave represents the more established, operationally proven enterprise. Nebius offers an earlier-stage opportunity with superior balance sheet health. The investment decision hinges on individual risk tolerance relative to potential appreciation.

Nebius’s consensus analyst target of $157.09 exceeds CoreWeave’s $121.06 objective, reflecting elevated growth assumptions embedded in the smaller competitor’s valuation.

✨ Limited Time Offer